top of page
Search
  • Writer's pictureBarry Laird

MENAC Breaking Results - ASCO2024

CCC member Tora Solheim will be presenting the results from a randomised, open-label trial of a multimodal intervention (exercise, nutrition and anti-inflammatory medication) plus standard care versus standard care alone to attenuate cachexia in patients with advanced cancer undergoing chemotherapy in an oral presentation at ASCO 2024.


8 views

Recent Posts

See All

Cachexia Trials Endpoints Reviews Series

The CCC in collaboration with an international group of experts in cachexia research are undertaking a series of extensive systematic reviews examining endpoints in cachexia clinical trials. Thus far

Comments


bottom of page